Leerink Swann Upgrades Health Management (HMA) to Outperform; Prepayment Audit Fears Overblown

Leerink Swann upgraded Health Management (NYSE: HMA) from Market Perform to Outperform, price target range $10-$11.

Leerink analyst says, "We are upgrading HMA shares as recent prepayment auditing concerns are overblown, in our view, and we expect continued upward revisions in earnings estimates as the company improves operations at recent acquisitions. HMA shares are trading at a P/E of less than 9x and an EV/EBITDA multiple of less than 6x our 2012 estimates."

For an analyst ratings summary and ratings history on Health Management click here. For more ratings news on Health Management click here.

Shares of Health Management closed at $7.47 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery